Loading...

LALPATHLAB Dr Lal Pathlabs Ltd Capital Structure Changes Announcement

Dr L

LLPT

Dr Lal Pathlabs Ltd

(LALPATHLAB)

2025 Announcement

Record Date for Bonus

Authorized Capital Increase

Complement lab launch

Analyst Meeting

Postal Ballot Notice

Q2 FY26 Results

Newspaper advertisement

Income tax assessment

Earnings Call Recording

Q2 Results Summary

Financial Results Q2

Earnings Presentation

2nd Interim Dividend

Employee RSU Introduction

Bonus Issue Approved

Financial Results

Dividend and Bonus

Earnings Call Announcement

Board Meeting Notice

Regulatory Compliance

Property Acquisition

Investor Meetings

Unclaimed Shares Notice

AI in Cancer Diagnosis

Earnings Call Transcript

Financial Results Publication

Earnings Call Audio

Q1 FY26 Earnings

Q1 Earnings Results

Earnings Call Update

Earnings Conference Call

Compliance Confirmation

Genomics Enhancement

AGM Notice Dispatch

Annual Report Weblink

Annual General Meeting

Amended Trust Deed

Investor Meetings

Newspaper Publication

Earnings Call Transcript

Financial Results Released

Earnings Call Recording

Earnings Presentation

Financial Results Q4

Appointment of Auditors

Director Re-appointments

Credit Rating Assigned

Earnings Call Notice

Secretarial Compliance Report

New Test Launch

Compliance Certificate

Stock Options Granted

Director Change

Investor Meeting

Voluntary Liquidation

Credit Rating Withdrawal

Postal Ballot Notice

Voluntary Liquidation

Q3 FY25 Earnings Call

Financial Results Published

Earnings Call Update

Earnings Presentation

Q3 Results Released

Code of Practices Update

Management Changes

Voluntary Liquidation Approval

Earnings Call Scheduled

Compliance Announcement

Registrar Name Change

Equity Share Allotment

Investor Meeting Scheduled

Investor Meeting Scheduled

Investor Meetings

Earnings Call Transcript

Financial Results

Earnings Call Recording

Earnings Presentation

Q2 Financial Results

Management Change

Earnings Call Announcement

Regulatory Compliance

Investor Meeting Scheduled

Subsidiary Dissolved

Investor Meeting

Unclaimed Shares Notice

Subsidiary Merger

Investor Meeting Schedule

Earnings Call Transcript

Management Change

Stock Options Granted

Stock Options Granted

Financial Results Publication

Meeting Intimation

Financial Results Announcement

Re-Appointment Announcement

Conference Call

Compliance Certificate Subm...

Newspaper Publication

30th AGM Notification

Meeting Intimation

Corporate Presentation

Financial Results Publication

Conference Call Outcome

Earnings Presentation

Earnings Presentation

Financial Results Announcement

AGM Announcement

Internal & Cost Auditors Ap...

Board Meeting Update

Investor Call Notice

Annual Compliance Report

Resignation Update

Newspaper Publication

Regulatory Compliance

Compliance Certificate

Compliance Certificate Subm...

Income Tax Assessment Order

CEO Appointment

Appointment of CEO

Meeting Schedule

Resignation of CEO

Meeting Intimation

Credit Rating Re-affirmed

Transcript Release

Investor Meetings

Financial Results Released

Earnings Presentation

Financial Results Announcement

Conference Call

Compliance Certificate Subm...

Allotment of ESOP Shares

Meeting Schedule

Conference Call Transcript

Conference Call Audio Recor...

Financial Results

Earnings Presentation

Authorization Details

Meeting Schedule

Conference Call Invitation

Compliance Certificate

Meeting Schedule

Schedule of Investor Meetings

Equity Shares Allotment

Conference Call

Director Resignations

Management Changes

Investor Meetings

Meetings with Analysts/Inve...

Analyst / Investor Meet

Equity Offerings

Financial Statements

Conference Call

Financial Statements

Financial Statements

Appointments, Resignations,...

Conference Call

Equity Offerings

Compliance Certificate

Analyst/Institutional Inves...

Analyst/Institutional Inves...

Meeting Schedules

One-on-One Meeting

Investor Meetings

Meetings with Analysts/Inve...

Analyst/Institutional Inves...

Analyst/Institutional Inves...

Equity Grant to Employees

Analyst/ Institutional Inve...

Financial Results Transcript

One-on-One Meeting

Conference Call

Financial Results Advertise...

Appointment of Company Secr...

Earnings Presentation

Financial Results

Investor Conference

External Links:

Data:

Dr. Lal PathLabs approved an increase in authorized share capital to ₹200 crore via MOA amendment following a postal ballot on December 7, 2025, expanding headroom for future equity issuances.

AI Assistant

Dr Lal Pathlabs Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.